A systematic review and meta-analysis of erythropoietin in experimental stroke.
about
The need for randomization in animal trials: an overview of systematic reviewsA call for transparent reporting to optimize the predictive value of preclinical researchSystematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and MetabolismCritical appraisal of studies using laboratory animal modelsNeuroprotection for stroke: current status and future perspectivesSystematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically.Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!High dose erythropoietin increases brain tissue oxygen tension in severe vasospasm after subarachnoid hemorrhagePromises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Systematic review and meta-analysis of therapeutic hypothermia in animal models of spinal cord injuryMeta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressureCombination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after ischemic stroke.Erythropoietin in stroke therapy: friend or foeAssociation of lower hemoglobin level and neuropathology in community-dwelling older personsAcute hemodynamic effects of erythropoietin do not mediate its cardioprotective properties.Erythropoietin update 2011Cerebral vasospasm pharmacological treatment: an updateSerum erythropoietin and outcome after ischaemic stroke: a prospective study.Erythropoietin: not just about erythropoiesis.Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke.Intranasal erythropoietin therapy in nervous system disorders.Neuroprotection for ischaemic stroke: translation from the bench to the bedside.Bringing rigour to translational medicine.Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives.High-dose erythropoietin for tissue protection.Systematic review of experimental studies on intestinal anastomosis.Statins and anti-inflammatory therapies for subarachnoid hemorrhage.EPO for stroke therapy - Is there a future for further clinical development?Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats.Protective effect of vitexin compound B-1 against hypoxia/reoxygenation-induced injury in differentiated PC12 cells via NADPH oxidase inhibition.Neuroprotective Effects of neuroEPO Using an In Vitro Model of Stroke.Treatments to Promote Neural Repair after Stroke.Drug treatment of cerebral vasospasm after subarachnoid hemorrhage following aneurysms
P2860
Q21559463-7396C44E-8139-4448-9D78-3E01170B6DB8Q24289327-BD3D273A-5BE4-4DDB-AA97-76EF11E040A5Q24289348-021110CE-03F3-4ED9-BA8B-2BFFD36EAAF7Q26829466-660D8DF8-6F01-438D-ABC1-5BF9F3B922AAQ26853031-49543610-5678-4B95-A3B8-41DDA87411FAQ33581177-5C5D7B2D-CD6A-4FEC-885B-34774712DDF9Q34164787-77D3E41A-3AF2-4FB3-8462-04AB47DC1693Q34294255-AFE18D20-6368-46A0-AF95-1A70CD0CD08CQ34504572-6BE1371C-2FBB-425C-A98A-BE57EA2B8AE9Q34949213-F1D42BA2-1503-45DC-A6C9-F188AF673FC9Q34979583-22293ABE-DB13-460E-8910-1884C8ECDDA5Q35225979-4ED3BF6A-0BC3-4B28-A859-CFAF113454F8Q35548966-15AFAEEE-929C-458F-AA2A-492542E864ACQ36395515-256B5020-830C-4F18-9CCB-8325289C3B47Q36425514-EA96E3F7-DAF7-4210-929B-17CAD225A1D6Q36516298-91DCE585-9360-4771-B6E1-3116A66BC149Q36610442-ECA049C0-6990-419B-B386-7ED3709BD216Q36625386-AD2B4BDD-75BA-41DC-A5FA-62D0731200D8Q36972360-B636AA7A-EC9D-4AC9-9239-9C9CA1C1BDC5Q37725913-207AC319-81C3-4CF7-8C58-669754C757F3Q37818329-E941DBDE-BD30-48B6-9121-D9C4056DDAD4Q37991061-DD5ABAEC-B32A-4D15-A23B-F17A02CECCA8Q38163820-A37F7342-AE42-4E01-8A6D-0F0432AB79AAQ38172120-52335D68-5944-41F7-897B-C2571472CDA8Q38262836-7252F67C-57E1-4205-8693-F8AED011C9D6Q38407969-B4A95F25-39FA-435D-BB3A-4CF6005FB5DAQ39663927-72FEFAD4-DF78-41CC-A378-501DEB6EEFF7Q39874402-957A6A30-44C1-4516-8710-AE8FE176DD0BQ44045737-F04071BA-2970-427D-8E47-BC877486838DQ46876851-05CC3343-2613-40BA-B4CB-DC2287E85699Q50042158-ECBCFF64-123E-40CD-928A-B5D9F599BC82Q50062335-6FB3AD56-3420-4210-A0B1-C262F2C5D915Q56428950-B21E792A-A5FA-475F-BD86-C49B85E4EC99
P2860
A systematic review and meta-analysis of erythropoietin in experimental stroke.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@ast
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@en
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@nl
type
label
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@ast
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@en
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@nl
prefLabel
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@ast
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@en
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@nl
P2093
P2860
P50
P356
P1476
A systematic review and meta-analysis of erythropoietin in experimental stroke.
@en
P2093
Kalle Forsberg
Mikael Jerndal
Thomas Linden
Victoria E O'Collins
P2860
P304
P356
10.1038/JCBFM.2009.267
P577
2009-12-30T00:00:00Z